default author photo

Satoshi Morita

Kyoto University - Department of Biomedical Statistics and Bioinformatics

SCHOLARLY PAPERS

3

DOWNLOADS

179

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Genomic and Transcriptomic Profiling of Triple Negative Breast Cancer Patients Treated with Paclitaxel and Eribulin Containing Neoadjuvant Chemotherapy and Response Prediction

Number of pages: 48 Posted: 17 Mar 2023
Kyoto University - Department of Next-generation Clinical Genomic Medicine, Kyoto University - Department of Breast Surgery, Nagoya University - Department of Breast and Endocrine Surgery, Kyoto University - Department of Breast Surgery, Kyoto University - Center for Genomic Medicine, Kyoto University - Department of Breast Surgery, Kyoto University - Department of Breast Surgery, Kyoto University - Department of Breast Surgery, Kobe City Medical Center General Hospital - Department of Breast Surgery, Hiroshima University - Department of Breast Surgery, University of Tsukuba - Breast and Endocrine Surgery, Chiba Cancer Center - Department of Breast Surgery, Kumamoto University - Department of Breast and Endocrine Surgery, Japanese Foundation for Cancer Research - Department of Breast Surgical Oncology, National Hospital Organization (NHO) - Department of Surgery, Saitama Medical University International Medical Center (SIMC) - Breast Oncology Service, Kyoto University - Department of Biomedical Statistics and Bioinformatics, Japanese Foundation for Cancer Research - Department of Breast Surgical Oncology, Diagnostic Pathology, Kyoto University Hospital, Kyoto University - Center for Genomic Medicine, Kyoto University - Department of Pathology and Tumor Biology and Kyoto University - Department of Breast Surgery
Downloads 102 (679,608)

Abstract:

Loading...

Triple negative breast cancer, HRD, microtubule inhibitors, eribulin, response, resistance

2.

Phase 2 Study of Osimertinib in Combination with Platinum and Pemetrexed in Patients with Previously Untreated EGFR–Mutated Advanced Non–Squamous Non–Small Cell Lung Cancer: The OPAL Study

Number of pages: 32 Posted: 03 Feb 2023
Tohoku University, Sendai Kousei Hospital - Department of Pulmonary Medicine, Juntendo University, Kurume University - Department of Internal Medicine, Akita Kousei Medical Center, Iwate Medical University, National Hospital Organization Hokkaido Medical Center, Juntendo University - Department of Respiratory Medicine, Saitama University - Saitama Medical University, Shimane University - Division of Medical Oncology and Respiratory Medicine, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Niigata University, Kyushu University - Kyushu University Hospital, Kyoto University - Department of Biomedical Statistics and Bioinformatics, Hokkaido University, Kyushu University - Kyushu University Hospital, Oita University and Saitama Medical University International Medical Center (SIMC)
Downloads 41 (1,170,409)

Abstract:

Loading...

non-small cell lung cancer, EGFR mutation, osimertinib, platinum-based chemotherapy, pemetrexed

3.

The Impact of COPD Treatment on Overall Survival in Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Multicenter Study

Number of pages: 28 Posted: 16 Nov 2025
Kyoto University, Kyoto University - Kyoto University Hospital, Kyoto University - Kyoto University Hospital, Kyoto University - Kyoto University Hospital, Kyoto University - Kyoto University Hospital, Kyoto University - Kyoto University Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, Kyoto University - Department of Respiratory Medicine, affiliation not provided to SSRN, affiliation not provided to SSRN, Kyoto Katsura Hospital, Japanese Red Cross Otsu Hospital, affiliation not provided to SSRN, Kyoto University - Department of Biomedical Statistics and Bioinformatics, Kyoto University and Kyoto University
Downloads 36 (1,236,159)

Abstract:

Loading...

lung cancer, COPD, LABA, LAMA, ICS, immune checkpoint inhibitor